High-dose chemotherapy with peripheral blood stem-cell transplantation for hormone-refractory advanced carcinoma of the prostate: Experience of two cases

International Journal of Urology

Volumn 3, Issue 4, 1996, Pages 320-323

  Nishiyama, Tsutomu ^a   Kishi, Kenji ^b   Deguchi, Takashi ^c   Mukaiyama, Taketo ^d   Terunuma, Masahiro ^a  

^a Nagaoka Chuo General Hospital   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

High dose chemotherapy; Hormone refractory prostate carcinoma; Micrometastatic contamination; Peripheral blood stem cell transplantation

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ESTRAMUSTINE PHOSPHATE; FLUOROURACIL; GONADORELIN AGONIST; MESSENGER RNA; METHOTREXATE; PROSTATE SPECIFIC ANTIGEN; THIOTEPA;

ADULT; ADVANCED CANCER; ARTICLE; CANCER REGRESSION; CASE REPORT; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029789401     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1996.tb00545.x     Document Type: Article

References (17)

1. Huggins C, Hodges CV. Studies on prostate cancer. Effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941;1:293-297.
2. Nichols CR, Andersen J, Lazarus HM, Fishier H, Greer J, Stadtmauer EA, Loehrer PJ, Trump DL. High-dose carboplatin and etoposide with autologous bone marrow transplantation in refractory germ cell cancer: an Eastern Cooperative Oncology Group protocol. J Clin Oncol 1992;10:558-563.
3. Nishiyama T, Kishi K, Shinada S, Kimura M, Komeyama K, Takahashi E. Terunuma M, Tomita Y, Kawakami Y, Tanikawa T, Hiraiwa M, Mineyama H. High-dose chemotherapy with autologous blood stem cell transplantation in the treatment of advanced testicular tumors: the experience of five cases. J Jpn Soc Cancer Ther 1994;29:741-757.
4. Peter WP, Shpall EJ, Jones RB, Olsen GA, Bast RC, Gockerman JP, Moore JO. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 1988;6:1368-137
5. Shpall EJ, Strinivas S, Madhavan S, Rearden TP. Use of doxorubicin and dose-escalated cyclophosphamide with granulocyte colony stimulating factor in the treatment of hormone refractory prostate cancer. Proc Annu Meet Am Soc Clin Oncol 1995;14:243.
6. Richman CM, Weiner RS, Yankee RA. Increase in circulating stem cells following chemotherapy in man. Blood 1976;47:1031-1039.
7. Bell AJ, Hamblin TJ, Oscier DG. Circulating stem cell autograft. Bone Marrow Transplant 1986;1:103-110.
8. Makino S, Harada M, Akashi K, Taniguchi S, Shibuya T, Inaba S, Niho Y. A simplified method for cryopreservation of peripheral blood stem cells at -80°C without rate-controlled freezing. Bone Marrow Transplant 1991;8:239-244.
9. Ross AA, Cooper BW, Lazarus HM, Mackey W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meaghar RC, Herzig RH, Klumpp TR, Kam DG, Warner NE. Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993;82:2605-2610.
10. Deguchi T, Doi T, Ehara H, Ito S, Takahashi Y, Nishino Y, Fujihiro S, Kawamura T, Komeda H, Horie M, Kaji H, Shimokawa K, Tanaka T, Kawada Y. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-5354.
11. Wood DP, Banks ER, Humphreys S, McRoberts JW, Rangnekar V. Identification of Done marrow micrometastases in patients with prostate cancer. Cancer 1994;74:2533-2540.
12. Shpall EJ, Jones RB, Bast RC Jr, Rosner GL, Vandermark R, Ross M, Affronti ML, Johnston C, Eggleston S, Tepperburg M. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol 1991; 9:85-93.
13. Shpall EJ, Bast RC Jr, Joines WT, Jones RB, Anderson I, Johnston C, Eggleston S, Tapperberg M, Edwards S, Peters WS. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant 1991;7:145-151.
14. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991;177: 1717-1722.
15. Dexeus F, Logothetis CJ, Samuels ML. Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer. Cancer Treat Rep 1985;69:885-886.
16. Hudes GR, Greengerg R, Krigel RL. Phase II study of estramustine and vinblastine, two microtubular inhibitors, in hormone-refractory prostate cancer. J Clin Oncol 1992;10:1754-1761.
17. Pienta KJ, Redman B, Hussain M, Cummings G, Esper PS, Appel C, Flaherty LE. Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Clin Oncol 1994;12:2005-2012.